AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis

AIM: Examine the efficacy of once-weekly subcutaneous tocilizumab (SC-TCZ) on joint damage at 24 weeks based on radiography of the hands and feet and magnetic resonance imaging (MRI) of the hand in subjects with moderate to severe rheumatoid arthritis (RA). METHODS: In this Australian open-label, mu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Rheumatol
Autores principales: Bird, Paul, Peterfy, Charles, Countryman, Peter, Griffiths, Hedley, Barrett, Rina, Youssef, Peter, Joshua, Fredrick, Hall, Stephen
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5925169/
https://ncbi.nlm.nih.gov/pubmed/29849651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8721753
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares